Drugs / Clarythromycin
last change Sep 2016 re-read 9 days ago

Clarythromycin

Developed for
Helicobacter pylori infectious disease · bacterial pneumonia · chronic bronchitis
Investigated by
EMS

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT02552641 Sep 2015 → Feb 2016 Helicobacter pylori infectious disease EMS Withdrawn No outcome recorded
Comparator or background therapy2 trials
Phase 4 NCT00713947 Comparator Apr 2008 → Mar 2009 coronary thrombosis Assistance Publique - Hôpitaux de Paris Withdrawn No outcome recorded
Phase 4 NCT00245453 Comparator Oct 2005 → Jul 2006 bacterial pneumonia, chronic bronchitis CPL Associates Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Clarythromycin “Amoxicillin, Clarythromycin or metronidazole,Pantoprazole,Placebo” NCT00713947 ↗
2

NCT00245453 ↗

NCT02552641 ↗